Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 177
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
PT321 – Lyle Maxson – Virtual Reality, Biofeedback, and Digital Therapeutics:...
Psychedelic Bulletin #103 – MAPS Phase 3 Trial On Schedule;...
PT320 – Anne Philippi – The New Health Club, Intergenerational Trauma,...
PT319 – Kole – Activism and Trust: A Cautionary Tale From...
DO-Why? The Story of DOI
Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety...
PT318 – Del Jolly, Rashad Evans, and Jake Plummer – Functional...
Update on the Fight for Religious Liberties in Oregon
Psychedelic Research Bulletin: April 2022
PT317 – Jason Grechanik – Ancient Wisdom, Plant Dietas, and The...
Load more